Pub Date : 2025-12-10eCollection Date: 2025-01-01DOI: 10.3205/oc000264
Konstantina Manoli, Jared Ching
Objective: We present a case of a macular horseshoe tear that demonstrated signs of progression over time that was therefore deemed sight threatening. There are no reports that provide a definitive means to treat such a rare pathology.
Methods: Spectral domain optical coherence tomography (SD-OCT) scans were used to monitor subretinal fluid at each follow up. Once confirmation of the accumulation of subretinal fluid was made, vitrectomy surgery including amputation of the horseshoe tear flap, short acting gas tamponade and face down positioning were utilized.
Results and conclusion: Macular horseshoe tears can be treated with a vitrectomy approach akin to retinal detachment repair without the need for retinopexy.
{"title":"A macular horseshoe tear following posterior vitreous detachment and longstanding branch retinal vein occlusion.","authors":"Konstantina Manoli, Jared Ching","doi":"10.3205/oc000264","DOIUrl":"10.3205/oc000264","url":null,"abstract":"<p><strong>Objective: </strong>We present a case of a macular horseshoe tear that demonstrated signs of progression over time that was therefore deemed sight threatening. There are no reports that provide a definitive means to treat such a rare pathology.</p><p><strong>Methods: </strong>Spectral domain optical coherence tomography (SD-OCT) scans were used to monitor subretinal fluid at each follow up. Once confirmation of the accumulation of subretinal fluid was made, vitrectomy surgery including amputation of the horseshoe tear flap, short acting gas tamponade and face down positioning were utilized.</p><p><strong>Results and conclusion: </strong>Macular horseshoe tears can be treated with a vitrectomy approach akin to retinal detachment repair without the need for retinopexy.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc16"},"PeriodicalIF":0.0,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05eCollection Date: 2025-01-01DOI: 10.3205/oc000263
Aluisio Rosa Gameiro Filho, Willian Gabriel Odorcik, Matheus Henrique Rocha Garcia, Marcelo Brillinger Novello, Daniella Socci da Costa
A 45-year-old woman with a 7-day history of fever and nausea sought assistance at the emergency department complaining of blurred vision in her right eye. She was recently diagnosed with dengue fever. Fundus showed a discrete well-circumscribed, round yellow-orange lesion localized in the foveal region, retinal hemorrhages, macular oedema, soft exudates, and adjacent perivasculitis in the affected eye. Spectral domain optical coherence tomography (OCT) was compatible with dengue maculopathy. She was closely followed, with complete improvement after 1 week. The increasing incidence of dengue makes essential for the ophthalmologist to recognize this rare condition.
{"title":"Dengue fever maculopathy: case report and brief review.","authors":"Aluisio Rosa Gameiro Filho, Willian Gabriel Odorcik, Matheus Henrique Rocha Garcia, Marcelo Brillinger Novello, Daniella Socci da Costa","doi":"10.3205/oc000263","DOIUrl":"10.3205/oc000263","url":null,"abstract":"<p><p>A 45-year-old woman with a 7-day history of fever and nausea sought assistance at the emergency department complaining of blurred vision in her right eye. She was recently diagnosed with dengue fever. Fundus showed a discrete well-circumscribed, round yellow-orange lesion localized in the foveal region, retinal hemorrhages, macular oedema, soft exudates, and adjacent perivasculitis in the affected eye. Spectral domain optical coherence tomography (OCT) was compatible with dengue maculopathy. She was closely followed, with complete improvement after 1 week. The increasing incidence of dengue makes essential for the ophthalmologist to recognize this rare condition.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc15"},"PeriodicalIF":0.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25eCollection Date: 2025-01-01DOI: 10.3205/oc000261
Igor Knezović, Nina Jovanović, Sara Djurić
Purpose: To present the results of two different surgical procedures, decentered individualized sphero-cylindrical protocol (DISC protocol) and Athens protocol, performed on a 34-year-old patient after being diagnosed with keratoconus in both eyes.
Observation: The patient's left eye was subjected to the Athens protocol (phototherapeutic keratectomy (PTK) + partial topo-guided photorefractive keratectomy (TG-PRK) + corneal cross-linking (CXL)). In contrast, the patient's right eye was subjected to the DISC protocol (PTK + DISC excimer ablation + CXL). After administration of topical anesthetic, the patient was subjected to PTK of the central 7 mm optical zone with 50 µm depth of epithelial ablation. After excimer laser ablation in both eyes, riboflavin 0.1% solution was applied topically every 2 minutes for 20 minutes. This was followed by five cycles of 5-minute-long irradiation (for 25 minutes) using a UVA 370 nm at 3.0 mW/cm2 CXL (CSO VEGA CMB X Linker, Florence, Italy) application. 36 months postoperative uncorrected visual acuity (UCVA) of the left eye remained the same as preoperatively, while the best corrected visual acuity (BCVA) was -3.5 Dsph=20/30. In the right eye, UCVA and BCVA were both 20/22. Results of Fourier's analysis of the right eye imply a 52% decrease in corneal irregularity, while in the left eye, corneal irregularity decreased by 12.8%. Values of spheric aberration in Zernike analysis 36 months postoperatively showed a lower increase in Athens protocol than DISC protocol. The index of vertical asymmetry and the index of surface variance showed lower values in both procedures during the whole postoperative period, while the index of height decentration showed a more significant decline in Athens protocol 36 months postoperatively.
Conclusion and importance: DISC protocol is a novel approach, with the potential to become a promising strategy for slowing the progression of keratoconus and recovering uncorrected visual abilities.
{"title":"Results of contralateral Athens and decentered individualized sphero-cylindrical (DISC) protocols for keratoconus management.","authors":"Igor Knezović, Nina Jovanović, Sara Djurić","doi":"10.3205/oc000261","DOIUrl":"10.3205/oc000261","url":null,"abstract":"<p><strong>Purpose: </strong>To present the results of two different surgical procedures, decentered individualized sphero-cylindrical protocol (DISC protocol) and Athens protocol, performed on a 34-year-old patient after being diagnosed with keratoconus in both eyes.</p><p><strong>Observation: </strong>The patient's left eye was subjected to the Athens protocol (phototherapeutic keratectomy (PTK) + partial topo-guided photorefractive keratectomy (TG-PRK) + corneal cross-linking (CXL)). In contrast, the patient's right eye was subjected to the DISC protocol (PTK + DISC excimer ablation + CXL). After administration of topical anesthetic, the patient was subjected to PTK of the central 7 mm optical zone with 50 µm depth of epithelial ablation. After excimer laser ablation in both eyes, riboflavin 0.1% solution was applied topically every 2 minutes for 20 minutes. This was followed by five cycles of 5-minute-long irradiation (for 25 minutes) using a UVA 370 nm at 3.0 mW/cm<sup>2</sup> CXL (CSO VEGA CMB X Linker, Florence, Italy) application. 36 months postoperative uncorrected visual acuity (UCVA) of the left eye remained the same as preoperatively, while the best corrected visual acuity (BCVA) was -3.5 Dsph=20/30. In the right eye, UCVA and BCVA were both 20/22. Results of Fourier's analysis of the right eye imply a 52% decrease in corneal irregularity, while in the left eye, corneal irregularity decreased by 12.8%. Values of spheric aberration in Zernike analysis 36 months postoperatively showed a lower increase in Athens protocol than DISC protocol. The index of vertical asymmetry and the index of surface variance showed lower values in both procedures during the whole postoperative period, while the index of height decentration showed a more significant decline in Athens protocol 36 months postoperatively.</p><p><strong>Conclusion and importance: </strong>DISC protocol is a novel approach, with the potential to become a promising strategy for slowing the progression of keratoconus and recovering uncorrected visual abilities.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc13"},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25eCollection Date: 2025-01-01DOI: 10.3205/oc000262
Víctor Manuel Asensio-Sánchez
Objective: To report a rare case of severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma, highlighting the ocular toxicities that may arise from immune checkpoint inhibitors.
Methods: A 38-year-old woman receiving ipilimumab (3 mg/kg every 3 weeks) for metastatic melanoma presented with painless bilateral vision loss following her third dose. Clinical assessment included visual acuity testing, fundus examination, fluorescein angiography (FA), and optical coherence tomography (OCT) to evaluate retinal changes. The ipilimumab treatment was discontinued, but the patient refused corticosteroid therapy.
Results: Fundus examination and OCT revealed bilateral serous retinal detachments with retinal pigment epithelium (RPE) detachment. FA demonstrated multiple pinpoint leakage areas at the RPE level. Over a three-month follow-up period, visual acuity further declined, resulting in total vision loss in one eye and persistent bilateral serous detachments despite cessation of ipilimumab.
Conclusions: This case highlights the potential for severe, irreversible vision loss due to ipilimumab-associated chorioretinopathy, underscoring the importance of early ophthalmological assessment and continuous monitoring in patients undergoing immune checkpoint inhibitor therapy. Early recognition and intervention are critical, especially when systemic corticosteroids are not administered.
{"title":"Severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma.","authors":"Víctor Manuel Asensio-Sánchez","doi":"10.3205/oc000262","DOIUrl":"10.3205/oc000262","url":null,"abstract":"<p><strong>Objective: </strong>To report a rare case of severe bilateral chorioretinopathy associated with ipilimumab in a patient with metastatic melanoma, highlighting the ocular toxicities that may arise from immune checkpoint inhibitors.</p><p><strong>Methods: </strong>A 38-year-old woman receiving ipilimumab (3 mg/kg every 3 weeks) for metastatic melanoma presented with painless bilateral vision loss following her third dose. Clinical assessment included visual acuity testing, fundus examination, fluorescein angiography (FA), and optical coherence tomography (OCT) to evaluate retinal changes. The ipilimumab treatment was discontinued, but the patient refused corticosteroid therapy.</p><p><strong>Results: </strong>Fundus examination and OCT revealed bilateral serous retinal detachments with retinal pigment epithelium (RPE) detachment. FA demonstrated multiple pinpoint leakage areas at the RPE level. Over a three-month follow-up period, visual acuity further declined, resulting in total vision loss in one eye and persistent bilateral serous detachments despite cessation of ipilimumab.</p><p><strong>Conclusions: </strong>This case highlights the potential for severe, irreversible vision loss due to ipilimumab-associated chorioretinopathy, underscoring the importance of early ophthalmological assessment and continuous monitoring in patients undergoing immune checkpoint inhibitor therapy. Early recognition and intervention are critical, especially when systemic corticosteroids are not administered.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc14"},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21eCollection Date: 2025-01-01DOI: 10.3205/oc000259
Şefik Can İpek, Seher Köksaldı
Objective: To report a case with a history of previous radial keratotomy who underwent refractive lens exchange with trifocal intraocular lenses.
Methods: Case report.
Results: A 69-year-old man underwent bilateral RK to correct myopia in both eyes elsewhere 40 years ago. He was admitted to our hospital due to progressive deterioration of vision. The uncorrected distance visual acuity in both eyes was 20/40, and the uncorrected near visual acuity (40 cm) was J10. On slit-lamp examination, mild cataract and four radial keratotomy incisions were found. The patient underwent bilateral refractive lens exchange with trifocal intraocular lenses one-week interval. We were unable to obtain the preoperative data or details of the patient's prior surgeries. Calculations were run with the American Society of Cataract and Refractive Surgery calculator using the Barret True K formula. Postoperative follow-up was continued for approximately six months. No perioperative complications were noted.
Conclusions: Six months after the surgery, the refractive outcomes for both eyes had stabilized, and no other complications had occurred. The patient was satisfied with the result.
{"title":"Refractive lens exchange with trifocal intraocular lens after radial keratotomy.","authors":"Şefik Can İpek, Seher Köksaldı","doi":"10.3205/oc000259","DOIUrl":"10.3205/oc000259","url":null,"abstract":"<p><strong>Objective: </strong>To report a case with a history of previous radial keratotomy who underwent refractive lens exchange with trifocal intraocular lenses.</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>A 69-year-old man underwent bilateral RK to correct myopia in both eyes elsewhere 40 years ago. He was admitted to our hospital due to progressive deterioration of vision. The uncorrected distance visual acuity in both eyes was 20/40, and the uncorrected near visual acuity (40 cm) was J10. On slit-lamp examination, mild cataract and four radial keratotomy incisions were found. The patient underwent bilateral refractive lens exchange with trifocal intraocular lenses one-week interval. We were unable to obtain the preoperative data or details of the patient's prior surgeries. Calculations were run with the American Society of Cataract and Refractive Surgery calculator using the Barret True K formula. Postoperative follow-up was continued for approximately six months. No perioperative complications were noted.</p><p><strong>Conclusions: </strong>Six months after the surgery, the refractive outcomes for both eyes had stabilized, and no other complications had occurred. The patient was satisfied with the result.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc11"},"PeriodicalIF":0.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present the case of an 18-year-old male who developed a black-colored growth on a bandage contact lens and cornea nine months after undergoing lamellar keratoplasty for advanced keratoconus in his left eye. The growth was identified as Aspergillus niger, which was successfully treated following its removal and microbiological examination.
{"title":"Delayed onset Aspergillus niger keratitis post-DALK associated with bandage contact lens: a case report highlighting the importance of vigilant postoperative care and management.","authors":"Dharamveer Singh Choudhary, Nolan Rodrigues, Jeba Shaheen, Sidhya Choudhary, Ajay Dhakad, Bhuvanesh Sukhlal Kalal","doi":"10.3205/oc000260","DOIUrl":"10.3205/oc000260","url":null,"abstract":"<p><p>We present the case of an 18-year-old male who developed a black-colored growth on a bandage contact lens and cornea nine months after undergoing lamellar keratoplasty for advanced keratoconus in his left eye. The growth was identified as Aspergillus niger, which was successfully treated following its removal and microbiological examination.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc12"},"PeriodicalIF":0.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-04eCollection Date: 2025-01-01DOI: 10.3205/oc000258
Marya Hameed, Fatima Siddiqui, Muhammad Khuzzaim Khan, Sindhura Tadisetty, Prasanna Kumar Gangishetti
Objective: Retinoblastoma (Rb) and Langerhans cell histiocytosis (LCH) are rare and distinct diseases that can coexist in a patient. We present a case report of a 5-year-old male who was diagnosed with bilateral retinoblastoma and LCH involving the skull and spine.
Methods: The patient underwent a detailed clinical evaluation, including a complete ophthalmic examination, neuroimaging studies, and bone marrow biopsy. A genetic test confirmed the presence of the BRAF V600E mutation in the LCH lesion. Treatment with BRAF inhibitors was initiated for LCH, followed by chemotherapy and left eye enucleation for retinoblastoma. The patient was monitored closely during treatment and at follow-up visits.
Results: The patient responded well to therapy, with no evidence of disease recurrence at 12-month follow-up and the enucleated eye was replaced with a prosthesis. The BRAF inhibitor was found to be an effective therapeutic option for the patient with BRAF-positive LCH.
Conclusion: Our case highlights the importance of early diagnosis and prompt treatment in managing complex cases with coexisting retinoblastoma and LCH. Treatment with BRAF inhibitors could be a promising therapeutic option for patients with BRAF-positive LCH. Further studies are needed to evaluate the efficacy and safety of BRAF inhibitors in the treatment of LCH. The long-term outcome and potential late effects of combined therapy for coexisting retinoblastoma and LCH should also be monitored closely.
{"title":"Treating metastatic extraocular retinoblastoma complicated with Langerhans cell histiocytosis.","authors":"Marya Hameed, Fatima Siddiqui, Muhammad Khuzzaim Khan, Sindhura Tadisetty, Prasanna Kumar Gangishetti","doi":"10.3205/oc000258","DOIUrl":"10.3205/oc000258","url":null,"abstract":"<p><strong>Objective: </strong>Retinoblastoma (Rb) and Langerhans cell histiocytosis (LCH) are rare and distinct diseases that can coexist in a patient. We present a case report of a 5-year-old male who was diagnosed with bilateral retinoblastoma and LCH involving the skull and spine.</p><p><strong>Methods: </strong>The patient underwent a detailed clinical evaluation, including a complete ophthalmic examination, neuroimaging studies, and bone marrow biopsy. A genetic test confirmed the presence of the BRAF V600E mutation in the LCH lesion. Treatment with BRAF inhibitors was initiated for LCH, followed by chemotherapy and left eye enucleation for retinoblastoma. The patient was monitored closely during treatment and at follow-up visits.</p><p><strong>Results: </strong>The patient responded well to therapy, with no evidence of disease recurrence at 12-month follow-up and the enucleated eye was replaced with a prosthesis. The BRAF inhibitor was found to be an effective therapeutic option for the patient with BRAF-positive LCH.</p><p><strong>Conclusion: </strong>Our case highlights the importance of early diagnosis and prompt treatment in managing complex cases with coexisting retinoblastoma and LCH. Treatment with BRAF inhibitors could be a promising therapeutic option for patients with BRAF-positive LCH. Further studies are needed to evaluate the efficacy and safety of BRAF inhibitors in the treatment of LCH. The long-term outcome and potential late effects of combined therapy for coexisting retinoblastoma and LCH should also be monitored closely.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc10"},"PeriodicalIF":0.0,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-02eCollection Date: 2025-01-01DOI: 10.3205/oc000257
Maria Lourdes Castro de Oliveira Figueiroa, Ricardo Danilo Chagas Oliveira, Gustavo Luiz Behrens Pinto, Maria Carolina Moura Costa Campos, Lizandra Almeida David da Silva Viana, Izabela Prado Viana, Mittermayer Barreto Santiago
Adult Still's disease (ASD) is a rare systemic inflammatory disorder for which ocular manifestations have rarely been described. We report a case of 38-year-old Brazilian woman with Purtscher-like retinopathy as a manifestation of ASD. She was diagnosed with Purtscher-like retinopathy based on fundoscopic findings, which revealed vasculitis with diffuse and bilateral perimacular cotton-wool exudates. She also presented with fever, arthritis, weight loss, and a diffuse cutaneous rash. Considering the severity of the retinopathy, she was initially treated with methylprednisolone pulse therapy and oral methotrexate, and later with infliximab, with the treatment changing due to partial recovery of vision loss. Purtscher-like retinopathy is a poor prognostic factor for ASD, as it can lead to permanent visual damage. Thus, early and aggressive immunosuppressive therapy is mandatory.
{"title":"Purtscher-like retinopathy as the manifestation of adult Still's disease.","authors":"Maria Lourdes Castro de Oliveira Figueiroa, Ricardo Danilo Chagas Oliveira, Gustavo Luiz Behrens Pinto, Maria Carolina Moura Costa Campos, Lizandra Almeida David da Silva Viana, Izabela Prado Viana, Mittermayer Barreto Santiago","doi":"10.3205/oc000257","DOIUrl":"10.3205/oc000257","url":null,"abstract":"<p><p>Adult Still's disease (ASD) is a rare systemic inflammatory disorder for which ocular manifestations have rarely been described. We report a case of 38-year-old Brazilian woman with Purtscher-like retinopathy as a manifestation of ASD. She was diagnosed with Purtscher-like retinopathy based on fundoscopic findings, which revealed vasculitis with diffuse and bilateral perimacular cotton-wool exudates. She also presented with fever, arthritis, weight loss, and a diffuse cutaneous rash. Considering the severity of the retinopathy, she was initially treated with methylprednisolone pulse therapy and oral methotrexate, and later with infliximab, with the treatment changing due to partial recovery of vision loss. Purtscher-like retinopathy is a poor prognostic factor for ASD, as it can lead to permanent visual damage. Thus, early and aggressive immunosuppressive therapy is mandatory.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc09"},"PeriodicalIF":0.0,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12587038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145460873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-26eCollection Date: 2025-01-01DOI: 10.3205/oc000256
Prabu Baskaran, Bharg Kariya, Anand Rajendran
Purpose: To describe the sequence of events in a case of high myope with myopic traction maculopathy.
Methods: Our female patient who is a high myope developed myopic choroidal neovascular membrane (CNVM), for which she received three anti-vascular endothelial growth factor injections (VEGF). It was scarred for a while. Later she developed myopic foveoschisis with macular detachment which progressed over a period with deterioration of vision.
Results: She underwent pars plana vitrectomy with silicone oil tamponade. Oil removal was done eight months later. At the last follow up visit, her macula was flat with stable vision.
Conclusion: Myopic traction maculopathy (MTM) is a challenging case to manage with its myriad of presentations and complex pathology.
{"title":"The sequence of events in six years of a myopic traction maculopathy.","authors":"Prabu Baskaran, Bharg Kariya, Anand Rajendran","doi":"10.3205/oc000256","DOIUrl":"10.3205/oc000256","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the sequence of events in a case of high myope with myopic traction maculopathy.</p><p><strong>Methods: </strong>Our female patient who is a high myope developed myopic choroidal neovascular membrane (CNVM), for which she received three anti-vascular endothelial growth factor injections (VEGF). It was scarred for a while. Later she developed myopic foveoschisis with macular detachment which progressed over a period with deterioration of vision.</p><p><strong>Results: </strong>She underwent pars plana vitrectomy with silicone oil tamponade. Oil removal was done eight months later. At the last follow up visit, her macula was flat with stable vision.</p><p><strong>Conclusion: </strong>Myopic traction maculopathy (MTM) is a challenging case to manage with its myriad of presentations and complex pathology.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc08"},"PeriodicalIF":0.0,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12447764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-15eCollection Date: 2025-01-01DOI: 10.3205/oc000255
Suher Abduraman, Bogdana Maliş, Ali Riza Cenk Celebi
Introduction: Metastatic breast cancer leads to significant challenges in terms of treatment and management, often requiring a multidisciplinary approach due to the potential side effects of chemotherapy and radiotherapy.
Case description: We present a case of a metastatic breast cancer patient with central serous chorioretinopathy, recurrent cystoid macular edema, and radiation-induced optic neuropathy that occurred after the treatment with paclitaxel and radiation. A 42-year-old female patient presented to our department with a one-week history of painless, subacute vision loss in her left eye, occurring one year after completing oncological treatment. Her best corrected visual acuity (BCVA) was 20/32 in her left eye, and the optical coherence tomography (OCT) showed central serous chorioretinopathy with spontaneous resolution within 1 month. Seven months later, she presented with a sudden decrease in vision in her right eye; the BCVA was 20/40, the relative afferent pupillary defect was found, and the visual field demonstrated a superior altitudinal defect corresponding to the inferior segmental optic nerve pallor, prompting us to start treatment with prednisolone. Six months later, her vision had fallen to light perception in the right eye and 20/25 in the left eye. The OCT findings were conclusive for cystoid macular edema in her left eye, so we started treatment with aflibercept. Unfortunately, we could not improve the visual outcome in the right eye, which had an amaurotic pupil. Regarding the left eye, the patient experienced recurrent macular edema treated with aflibercept. After several episodes, the patient's BCVA decreased to 20/50 without any improvement.
Conclusion: Herein we stated a young patient with metastatic breast cancer who developed a rare and unusual overlap of side effects: paclitaxel-associated retinopathy and radiation-induced optic neuropathy. We aim to illustrate the challenge of managing advanced breast cancer patients and emphasize the importance of careful monitoring for ocular complications, which can impact the patient's quality of life.
{"title":"Taxane-associated retinopathy and radiation-induced optic neuropathy in a young female patient with metastatic breast cancer.","authors":"Suher Abduraman, Bogdana Maliş, Ali Riza Cenk Celebi","doi":"10.3205/oc000255","DOIUrl":"10.3205/oc000255","url":null,"abstract":"<p><strong>Introduction: </strong>Metastatic breast cancer leads to significant challenges in terms of treatment and management, often requiring a multidisciplinary approach due to the potential side effects of chemotherapy and radiotherapy.</p><p><strong>Case description: </strong>We present a case of a metastatic breast cancer patient with central serous chorioretinopathy, recurrent cystoid macular edema, and radiation-induced optic neuropathy that occurred after the treatment with paclitaxel and radiation. A 42-year-old female patient presented to our department with a one-week history of painless, subacute vision loss in her left eye, occurring one year after completing oncological treatment. Her best corrected visual acuity (BCVA) was 20/32 in her left eye, and the optical coherence tomography (OCT) showed central serous chorioretinopathy with spontaneous resolution within 1 month. Seven months later, she presented with a sudden decrease in vision in her right eye; the BCVA was 20/40, the relative afferent pupillary defect was found, and the visual field demonstrated a superior altitudinal defect corresponding to the inferior segmental optic nerve pallor, prompting us to start treatment with prednisolone. Six months later, her vision had fallen to light perception in the right eye and 20/25 in the left eye. The OCT findings were conclusive for cystoid macular edema in her left eye, so we started treatment with aflibercept. Unfortunately, we could not improve the visual outcome in the right eye, which had an amaurotic pupil. Regarding the left eye, the patient experienced recurrent macular edema treated with aflibercept. After several episodes, the patient's BCVA decreased to 20/50 without any improvement.</p><p><strong>Conclusion: </strong>Herein we stated a young patient with metastatic breast cancer who developed a rare and unusual overlap of side effects: paclitaxel-associated retinopathy and radiation-induced optic neuropathy. We aim to illustrate the challenge of managing advanced breast cancer patients and emphasize the importance of careful monitoring for ocular complications, which can impact the patient's quality of life.</p>","PeriodicalId":73178,"journal":{"name":"GMS ophthalmology cases","volume":"15 ","pages":"Doc07"},"PeriodicalIF":0.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144981089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}